| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0003 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |